ArticleJCO oncology advances2025

Outcomes of Patients with Rare Cancers Treated with Combination Immune Checkpoint Inhibitors With and Without Prior anti-PD-1/L1 Exposure (NCI/SWOG S1609).

Megan Othus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.